Systemic retinoids for treatment of recalcitrant IgA pemphigus

Orphanet J Rare Dis. 2018 Sep 18;13(1):163. doi: 10.1186/s13023-018-0899-y.

Abstract

IgA pemphigus is an exceedingly rare autoimmune blistering disorder, caused by IgA autoantibodies against desmosomal proteins. No treatment option has been found to be universally effective. The disease is often recalcitrant to oral steroids and immunosuppressants. Here, we describe the use of systemic retinoids for the treatment of recalcitrant IgA pemphigus in 3 cases. Although the use of acitretin has been reported before, we present for the first time the positive effects of alitretinoin in treatment of 2 patients with IgA pemphigus. Besides hyperlipoproteinaemia requiring use of hypolipidemic agents in one case, alitretinoin was well-tolerated and has generally a more favorable side effect spectrum than immunosuppressants.

Keywords: Acitretin; Alitretoin; Autoimmune skin blistering; Desmocollin; Desmosomes.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alitretinoin / administration & dosage
  • Alitretinoin / therapeutic use*
  • Female
  • Fluorescent Antibody Technique, Direct
  • Humans
  • Immunoglobulin A / metabolism*
  • Pemphigus / drug therapy*
  • Pemphigus / metabolism*
  • Pemphigus / pathology
  • Retinoids / administration & dosage
  • Retinoids / therapeutic use*

Substances

  • Immunoglobulin A
  • Retinoids
  • Alitretinoin